The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Open accessAbstract
Types 1 and 2 diabetes affect some 380 million people worldwide. Both ultimately result from a deficiency of functional pancreatic insulin-producing beta cells. Beta cells proliferate in humans during a brief temporal window beginning around the time of birth, with a peak percentage (∼2%) engaged in the cell cycle in the first year of life. In embryonic life and after early childhood, beta cell replication is barely detectable. Whereas beta cell expansion seems an obvious therapeutic approach to beta cell deficiency, adult human beta cells have proven recalcitrant to such efforts. Hence, there remains an urgent need for antidiabetic therapeutic agents that can induce regeneration and expansion of adult human beta cells in vivo or ex vivo. Here, using a high-throughput small-molecule screen (HTS), we find that analogs of the small molecule harmine function as a new class of human beta cell mitogenic compounds. We also define dual-specificity tyrosine-regulated kinase-1a (DYRK1A) as the likely target of harmine and the nuclear factors of activated T cells (NFAT) family of transcription factors as likely mediators of human beta cell proliferation and differentiation. Using three different mouse and human islet in vivo–based models, we show that harmine is able to induce beta cell proliferation, increase islet mass and improve glycemic control. These observations suggest that harmine analogs may have unique therapeutic promise for human diabetes therapy. Enhancing the potency and beta cell specificity of these compounds are important future challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Bretones, G., Delgado, M. D., & León, J. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.013 · Cited by 747
Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683
Pelengaris, S., Khan, M., & Evan, G. I. (2002) · Cell · doi:10.1016/s0092-8674(02)00738-9 · Cited by 626
Genetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy
Sogno Valin, P., Proverbio, M. C., Diceglie, C., Gessi, A., di Candia, S., Mariani, B., Zamproni, I., Mangano, E., Asselta, R., Battaglia, C., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350827 · Cited by 552
Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function
Heit, J. J., Apelqvist, Å. A., Gu, X., Winslow, M. M., Neilson, J. R., Crabtree, G. R., & Kim, S. K. (2006) · Nature · doi:10.1038/nature05097 · Cited by 444
β-Cell Mass and Turnover in Humans
Saisho, Y., Butler, A. E., Manesso, E., Elashoff, D., Rizza, R. A., & Butler, P. C. (2013) · Diabetes Care · doi:10.2337/dc12-0421 · Cited by 402
Analysis of C-MYC Function in Normal Cells via Conditional Gene-Targeted Mutation
de Alboran, I. M., O'Hagan, R. C., Gärtner, F., Malynn, B., Davidson, L., Rickert, R., Rajewsky, K., DePinho, R. A., & Alt, F. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00088-7 · Cited by 398
Kassem, S. A., Ariel, I., Thornton, P. S., Scheimberg, I., & Glaser, B. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1325 · Cited by 361
Formation of a human β-cell population within pancreatic islets is set early in life
Gregg, B. E., Moore, P. C., Demozay, D., Hall, B. A., Li, M., Husain, A., Wright, A. J., Atkinson, M. A., & Rhodes, C. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1206 · Cited by 344
Fotaki, V., Dierssen, M., Alcántara, S., Martínez, S., Martí, E., Casas, C., Visa, J., Soriano, E., Estivill, X., & Arbonés, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6636-6647.2002 · Cited by 338
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
Ogawa, Y., Nonaka, Y., Goto, T., Ohnishi, E., Hiramatsu, T., Kii, I., Yoshida, M., Ikura, T., Onogi, H., Shibuya, H., et al. (2010) · Nature Communications · doi:10.1038/ncomms1090 · Cited by 276
Human β-Cell Proliferation and Intracellular Signaling
Kulkarni, R. N., Mizrachi, E.-B., Ocana, A. G., & Stewart, A. F. (2012) · Diabetes · doi:10.2337/db12-0018 · Cited by 236
Self-citationActivation, regulation, and inhibition of DYRK1A
Becker, W., & Sippl, W. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07956.x · Cited by 227
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
The Small Molecule Harmine Is an Antidiabetic Cell-Type-Specific Regulator of PPARγ Expression
Waki, H., Park, K. W., Mitro, N., Pei, L., Damoiseaux, R., Wilpitz, D. C., Reue, K., Saez, E., & Tontonoz, P. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.010 · Cited by 202
Tahtouh, T., Elkins, J. M., Filippakopoulos, P., Soundararajan, M., Burgy, G., Durieu, E., Cochet, C., Schmid, R. S., Lo, D. C., Delhommel, F., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301034u · Cited by 198
Improved low molecular weight Myc-Max inhibitors
Wang, H., Hammoudeh, D. I., Follis, A. V., Reese, B. E., Lazo, J. S., Metallo, S. J., & Prochownik, E. V. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0005 · Cited by 190
Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome
Nica, A. C., Ongen, H., Irminger, J.-C., Bosco, D., Berney, T., Antonarakis, S. E., Halban, P. A., & Dermitzakis, E. T. (2013) · Genome Research · doi:10.1101/gr.150706.112 · Cited by 189
Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens
Chung, N., Zhang, X. D., Kreamer, A., Locco, L., Kuan, P.-F., Bartz, S., Linsley, P. S., Ferrer, M., & Strulovici, B. (2008) · SLAS Discovery · doi:10.1177/1087057107312035 · Cited by 183
Lymphocyte calcium signaling from membrane to nucleus
Gallo, E. M., Canté-Barrett, K., & Crabtree, G. R. (2006) · Nature Immunology · doi:10.1038/ni1295 · Cited by 183
GABA Promotes Human β-Cell Proliferation and Modulates Glucose Homeostasis
Purwana, I., Zheng, J., Li, X., Deurloo, M., Son, D. O., Zhang, Z., Liang, C., Shen, E., Tadkase, A., Feng, Z.-P., et al. (2014) · Diabetes · doi:10.2337/db14-0153 · Cited by 183
The ups and downs of Myc biology
Soucek, L., & Evan, G. I. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.001 · Cited by 171
Bernal-Mizrachi, E., Kulkarni, R. N., Scott, D. K., Mauvais-Jarvis, F., Stewart, A. F., & Garcia-Ocaña, A. (2014) · Diabetes · doi:10.2337/db13-1146 · Cited by 171
Self-citationLaybutt, D. R., Weir, G. C., Kaneto, H., Lebet, J., Palmiter, R. D., Sharma, A., & Bonner-Weir, S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1793 · Cited by 144
Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
Brierley, D. I., & Davidson, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.06.001 · Cited by 140
Fiaschi‐Taesch, N., Salim, F. G., Kleinberger, J. W., Troxell, R., Cózar‐Castellano, I., Selk, K. L., Cherok, E., Takane, K. K., Scott, D. K., & Stewart, A. F. (2010) · Diabetes · doi:10.2337/db09-1776 · Cited by 137
Self-citationRegulation of Pancreatic β-Cell Regeneration in the Normoglycemic 60% Partial-Pancreatectomy Mouse
Peshavaria, M., Larmie, B. L., Lausier, J., Satish, B., Habibovic, A., Roskens, V. A., LaRock, K., Everill, B., Leahy, J. L., & Jetton, T. L. (2006) · Diabetes · doi:10.2337/db06-0017 · Cited by 128
Fiaschi‐Taesch, N., Bigatel, T. A., Sicari, B. M., Takane, K. K., Salim, F. G., Velázquez-García, S., Harb, G., Selk, K. L., Cózar‐Castellano, I., & Stewart, A. F. (2009) · Diabetes · doi:10.2337/db08-0631 · Cited by 117
Self-citationHuman CDC2-Like Kinase 1 (CLK1): A Novel Target for Alzheimer’s Disease
Jain, P., Karthikeyan, C., Moorthy, N. S. H. N., Waiker, D. K., Jain, A. K., & Trivedi, P. (2014) · Current Drug Targets · doi:10.2174/1389450115666140226112321 · Cited by 111
Neonatal β Cell Development in Mice and Humans Is Regulated by Calcineurin/NFAT
Goodyer, W. R., Gu, X., Liu, Y., Bottino, R., Crabtree, G. R., & Kim, S. K. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.05.014 · Cited by 110
ChREBP Mediates Glucose-Stimulated Pancreatic β-Cell Proliferation
Metukuri, M. R., Zhang, P., Basantani, M. K., Chin, C., Stamateris, R. E., Alonso, L. C., Takane, K. K., Gramignoli, R., Strom, S. C., O'Doherty, R. M., et al. (2012) · Diabetes · doi:10.2337/db11-0802 · Cited by 106
Self-citationRegulated β-Cell Regeneration in the Adult Mouse Pancreas
Cano, D. A., Rulifson, I. C., Heiser, P. W., Swigart, L. B., Pelengaris, S., German, M. S., Evan, G. I., Bluestone, J. A., & Hebrok, M. (2007) · Diabetes · doi:10.2337/db07-0913 · Cited by 105
Small-Molecule Inducer of β Cell Proliferation Identified by High-Throughput Screening
Shen, W., Tremblay, M. S., Deshmukh, V. A., Wang, W., Filippi, C. M., Harb, G., Zhang, Y.-Q., Kamireddy, A., Baaten, J., Jin, Q., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309304m · Cited by 99
Identification of small-molecule inducers of pancreatic β-cell expansion
Wang, W., Walker, J. R., Wang, X., Tremblay, M. S., Lee, J. W., Wu, X., & Schultz, P. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811848106 · Cited by 94
Mechanism of dual specificity kinase activity of DYRK 1 A
Walte, A., Rüben, K., Birner‐Gruenberger, R., Preisinger, C., Bamberg‐Lemper, S., Hilz, N., Bracher, F., & Becker, W. B. (2013) · FEBS Journal · doi:10.1111/febs.12411 · Cited by 75
Hepatocyte Growth Factor/c-Met Signaling Is Required for β-Cell Regeneration
Álvarez-Pérez, J. C., Ernst, S., Demirci, C., Casinelli, G. P., Mellado‐Gil, J. M., Rausell-Palamos, F., Vasavada, R. C., & García-Ocaña, A. (2013) · Diabetes · doi:10.2337/db13-0333 · Cited by 74
Menin determines K-RAS proliferative outputs in endocrine cells
Chamberlain, C. E., Scheel, D. W., McGlynn, K., Kim, H., Miyatsuka, T., Wang, J., Nguyen, V. Q., Zhao, S., Mavropoulos, A., Abraham, A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69004 · Cited by 70
Cell cycle control of β-cell replication in the prenatal and postnatal human pancreas
Köhler, C. U., Olewinski, M., Tannapfel, A., Schmidt, W. E., Fritsch, H., & Meier, J. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00496.2010 · Cited by 64
Demozay, D., Tsunekawa, S., Briaud, I., Shah, R., & Rhodes, C. J. (2011) · Diabetes · doi:10.2337/db11-0341 · Cited by 61
Cózar‐Castellano, I., Harb, G., Selk, K. L., Takane, K. K., Vasavada, R. C., Sicari, B. M., Law, B. K., Zhang, P., Scott, D. K., Fiaschi‐Taesch, N., et al. (2008) · Diabetes · doi:10.2337/db08-0393 · Cited by 59
Self-citationHepatocyte growth factor enhances engraftment and function of nonhuman primate islets
Fiaschi-Taesch, N. M., Berman, D. M., Sicari, B. M., Takane, K. K., Garcia-Ocaña, A., Ricordi, C., Kenyon, N. S., & Stewart, A. F. (2008) · Diabetes · doi:10.2337/db08-1085 · Cited by 59
Self-citationFrench, E. K., Kleinberger, J. W., Salim, F. G., Cox, A. E., Takane, K. K., Scott, D. K., & Stewart, A. F. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1074 · Cited by 53
Self-citationDyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance
Rachdi, L., Kariyawasam, D., Aïello, V., Hérault, Y., Janel, N., Delabar, J. M., Polak, M., & Scharfmann, R. (2014) · Cell Cycle · doi:10.4161/cc.29250 · Cited by 52
Finch, A. J., Prescott, J. E., Shchors, K., Hunt, A. E., Soucek, L., Dansen, T. B., Swigart, L. B., & Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.017 · Cited by 49
Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass
Rachdi, L., Kariyawasam, D., Guez, F., Aïello, V., Arbonés, M. L., Janel, N., Delabar, J. M., Polak, M., & Scharfmann, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3174-3 · Cited by 40
Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris, S., & Khan, M. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080307 · Cited by 38
Oncogenic co-operation in -cell tumorigenesis
Pelengaris, S., & Khan, M. (2001) · Cited by 6
Cited by
Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R., & Speier, S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.019 · Cited by 489
Natural Products for the Treatment of Type 2 Diabetes Mellitus
Ríos, J., Francini, F., & Schinella, G. (2015) · Planta Medica · doi:10.1055/s-0035-1546131 · Cited by 446
Single-Cell Transcriptomics of the Human Endocrine Pancreas
Wang, Y. J., Schug, J., Won, K.-J., Liu, C., Naji, A., Avrahami, D., Golson, M. L., & Kaestner, K. H. (2016) · Diabetes · doi:10.2337/db16-0405 · Cited by 432
Zhou, Q., & Melton, D. A. (2018) · Nature · doi:10.1038/s41586-018-0088-0 · Cited by 385
Wang, P., Karakose, E., Liu, H., Swartz, E., Ackeifi, C., Zlatanic, V., Wilson, J., González, B. J., Bender, A., Takane, K. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.005 · Cited by 162
Self-citation
Metadata
- Authors
- Wang, P., Alvarez-Perez, J.-C., Felsenfeld, D. P., Liu, H., Sivendran, S., Bender, A., Kumar, A., Sanchez, R., Scott, D. K., Garcia-Ocaña, A., & Stewart, A. F.
- Venue
- Nature Medicine
- Published
- 2015-03-09
- Volume
- 21
- Issue
- 4
- Pages
- 383-388
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2003454094
- Cited by
- 404
- References
- 51
- FWCI
- 31.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.